Molteni Farmaceutici’s

Molteni Farmaceutici’s new plant in Florence is a modern facility, with innovative technological and scientific equipment, at the forefront in terms of quality and production volumes, and highly qualified staff; its flagship is its firm aseptic manufacture technology of injectable solutions, employed in several business units structured according to their production capacity and pharmaceutical form.

In 2014 a new controlled contamination department for the production of narcotic nasal sprays was established; at present it is an European platform for the manufacture of a pain drug.

Molteni Farmaceutici entered the new millennium as a protagonist thanks to the intensive, high-level research activity being carried out at its own operating unit and with the collaboration of prestigious universities.

In particular, in the therapeutic area of addictions, a scouting process is underway for new molecules in the early stage phase and new indications, concentrations and formulations are being developed and registered to ensure an increasing compliance and adherence to narcotic drugs treatments. In the field of pain treatment, the aim is to consolidate its position in the specialist sector through a portfolio management strategy that also involves the acquisition of international licenses for innovative products.

2006 sees the founding of Molteni Therapeutics, which successfully develops innovative products in the field of photodynamic therapy. This company concluded in 2015 the first European authorized treatment of diabetic foot ulcers using photo-dynamic therapy.